genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2020
Onyx Pharmaceuticals
Sponsored
Rapid Target Discovery in Microbes Enabled by Onyx™ Platform
News
Amgen Eliminating 300 Onyx Jobs, Consolidating Cancer Operations
Cancer
Sorafenib-Capecitabine Combination Fails Phase III Trial
News
GEN’s List of Top Pharma and Biotech Firms
Cancer
Amgen Grows Cancer Holdings with $10.4B Onyx Acquisition
Industry News
Onyx Spurns Amgen Offer, Pursues Its Own Deal
Cancer
Onyx, UCSF Forge Cancer Innovation Alliance
Insights
People in the News
Insights
People in the News
Cancer
Nexavar Fails to Meet Primary Endpoint in Late-Stage NSCLC Study
1
2
3
Page 1 of 3
Scroll Up